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INTRODUCTION
Pediatric pulmonary thromboembolism has historically 
been considered as rare with relatively little information 
present in the medical literature regarding its imaging 
evaluation. Buck et al. (1) have performed a retrospective 
review of 3600 pediatric autopsy patients and reported 
that the incidence of pulmonary thromboembolism 
is 3.7%. Additionally, they have found that massive 
pulmonary thromboembolism has contributed to death 
in 31% of cases. With increased use of advanced cross-
section imaging, particularly computed tomography 
pulmonary angiography (CTPA), the prevalence of 
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pediatric pulmonary thromboembolism has been found 
to be more common than previously thought. In recent 
articles by Kritsaneepaiboon et al. (2) and Victoria et al. 
(3), pulmonary thromboembolism prevalence in children 
who underwent CTPA for clinically suspected pulmonary 
thromboembolism ranged from 14% to 15.5%. Given these 
important findings, it is imperative for radiologist to be 
aware of the most recent advances in CT evaluation of 
pediatric pulmonary thromboembolism. In order to facilitate 
the understanding of pulmonary thromboembolism in the 
pediatric population, this article reviewed the underlying 
pathophysiology of pulmonary thromboembolism, clinical 
presentation, risk factors including recently published risk 
factor algorithm, CT techniques, imaging evaluation, the 
spectrum of imaging findings in both acute and chronic 
pulmonary embolism, and alternative diagnoses that may 
be seen for children who were clinically suspected of 
pulmonary thromboembolism but without the presence or 
findings of pulmonary thromboembolism. 
Pathophysiology
In adults, multiple studies have demonstrated that clot 
is most commonly originated from the lower extremity 
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venous valve pockets. However, in the pediatric population, 
the upper extremity veins play more prominent roles (4-
9). Unlike adults where pulmonary thromboembolism 
is idiopathic in nearly one-third of patients, children 
with pulmonary thromboembolism have an identifiable 
risk factor in 96–98% of cases (10, 11). Given the high 
prevalence of risk factors in the pediatric population, 
d-dimer measurement is less reliable. Therefore, it is not 
routinely used as it is often elevated by underlying risk 
factors regardless of the presence or absence of pulmonary 
thromboembolism (10, 12, 13). 
Once pulmonary thromboembolism is developed, its 
physiological effects are dependent on vasoactive mediator 
presence, the amount of pulmonary circulation obstructed, 
and the concomitant cardiopulmonary disease. Pulmonary 
thromboembolism obstructing < 50% of pulmonary 
circulation are often clinically silent without underlying 
cardiopulmonary disease (10, 12). When pulmonary 
circulation involvement exceeds 50%, significant increases 
in the right ventricular afterload will occur, leading to right 
ventricular dilatation, increased pulmonary arterial pressure, 
and higher right ventricular pressure (10). In cases of 
pulmonary arterial hypertension, the left main coronary 
artery is compressed by the enlarged main pulmonary 
artery, resulting in cardiac ischemia and ultimately leading 
to hypotension due to diminished cardiac output (10).
Clinical Presentation
The classic PE presentation of hemoptysis, shortness 
of breath, and pleuritic chest pain is often not seen 
in children unless a large amount of pulmonary 
thromboembolism is present (10, 14, 15). Thus, pediatric 
pulmonary thromboembolism often presents with subtle and 
vague symptoms that can mimic other pulmonary diseases. 
Children often have excellent cardiac reserve to help them 
compensate for a large pulmonary thromboembolism 
burden. Thus, a high clinical suspicion is vital. Affected 
older children most commonly (84% of cases) present 
with pleuritic chest pain (16). Pediatric patients may also 
present with dysrhythmia, syncope, unexplained tachypnea, 
hypotension, and right heart failure. Of note, tachypnea is 
an important indicator of pulmonary thromboembolism in 
all pediatric patients (10, 17).
Risk Stratification Algorithm
Well-defined and widely utilized algorithms have been 
established to manage pulmonary embolism for adults. 
However, pediatric pulmonary thromboembolism prediction 
algorithms are just now coming to light. In a recent 
study for 227 CTPA performed in 227 patients who are 
clinically suspected of having pulmonary thromboembolism, 
the following five statistically significant risk factors 
for pulmonary thromboembolism have been found: 
immobilization, hypercoagulable state, excess estrogen 
state, indwelling central venous catheters (CVC), and 
prior pulmonary thromboembolism and/or deep venous 
thrombosis (Table 1) (18). Of 36 patients who were positive 
for pulmonary emboli, 37% were located in segmental 
pulmonary arteries, 31% were in lobar pulmonary arteries, 
23% were in subsegmental pulmonary arteries, and 9% 
were in main or central pulmonary arteries. In patients 
with pulmonary thromboembolism, immobilization (75%) 
was the most common risk factor, followed by CVC (56%), 
prior pulmonary emboli and/or deep venous thrombosis 
(44%), hypercoagulable state (22%), and excess estrogen 
state, i.e., oral contraceptive usage (22%). Two of 36 
patients were found to have pulmonary thromboembolism 
on CTPA without identifiable risk factors. Conversely, 
of 191 pediatric patients who were found not to have 
pulmonary thromboembolism on CTPA, no risk factor was 
found in 121 patients (63%). In those patients who were 
negative for pulmonary thromboembolism, 59 (31%) had 
one risk factor while 11 (6%) had two risk factors. None 
of the patients without pulmonary thromboembolism had 
Table 1. Significant Independent Risk Factors for Pulmonary Thromboembolism
Risk Factor β Coefficient Odds Ratio 95% CI P
Immobilization 4.87 130.5 25.0, 681.8 < 0.001
Hypercoagulable state 3.06 21.4 3.5, 131.5 0.003
Excess estrogen state 2.58 13.2 1.5, 123.7 0.002
Indwelling CVL 3.28 26.4 5.5, 127.2 < 0.001
Prior PE and/or DVT 1.96 7.1 2.0, 27.2 < 0.001
Reprinted from Lee et al. Radiology 2012;262:242-251, with permission of Radiological Society of North America (18). CI = confidence 
interval, CVL = central venous line, DVT = deep venous thrombosis, PE = pulmonary thromboembolism
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greater than two risk factors. The authors were able to 
calculate the probability of pulmonary thromboembolism 
based on the number of risk factors present (Table 2). In 
the absence of any risk factor, the probability of pulmonary 
thromboembolism was found to be 0.5%. With one risk 
factor, the probability was 8%. Pulmonary thromboembolism 
probability with two and three or more risk factors was 
62% and 89%, respectively. With two or more of these risk 
factors as clinical threshold, the sensitivity and specificity 
for a positive pulmonary thromboembolism were 89% and 
94%, respectively. Thus, the authors concluded that clinical 
assessment for these five risk factors should be employed 
as a first-line triage method to determine the necessity of 
imaging evaluation (Fig. 1) (18). Of note, in that study, 
the authors found no significant difference in age or sex 
of patients with pulmonary thromboembolism compared 
to those who did not have pulmonary thromboembolism. 
However, in neonates, CVC with associated thrombus has 
been found in 80% of cases (10, 14, 19). After the neonatal 
period, the single greatest risk factor is the presence 
of a CVC. However, additional risk factors begin to have 
increasing roles.
CT Technique
Patient Preparation
To perform CTPA, patient preparation is primarily based 
on whether sedation is required and what size intravenous 
catheter is utilized. For patients ≥ 5 years of age who can 
follow breathing instructions, sedation is generally not 
required. By contrast, infants and children less than 5 years 
old are generally sedated for CTPA. Since newer generation 
scanners have the capability of scanning the entire chest 
with sub-second scan times, sedation is less likely to be 
utilized. At our institutions, CTPA studies are performed with 
nonionic contrast at a dose of 2 mL/kg (not to exceed 4 mL/
kg or 125 mL). Contrast may be injected either manually or 
by power injection if the patient has a secure antecubital 
catheter. Power injection rates are 3 mL/s for a 20-gauge 
catheter, 1.5–2.0 mL/s for a 22-gauge catheter, and 1.0 mL/
s for a 24-gauge catheter. If the catheter is placed in the 
hand or foot, manual injection is generally performed with an 
injection rate of approximate 1 mL/s. Contrast administration 
should be closely monitored during the initial injection to 
minimize contrast extravasation risk (2).
CT Parameters
Patients are placed in supine position with an initial scout 
radiographic image acquired to define scan coverage so that 
the entirety of both lungs and from the level of the thoracic 
inlet to the diaphragms are covered. Scanning direction can 
be either craniocaudal or caudocranial. Acquiring images in 
the caudal-cranial direction may be useful given the higher 
prevalence of pulmonary embolism in the lower lobes. By 
acquiring images of the lower lobes first, one can reduce 
the chance that emboli may be obscured by respiratory 
motion in a patient who cannot hold their breath for the 
entire examination (2, 20). Kilovoltage and tube current 
Table 2. Simplified Algorithm of Number of Risk Factors and 
Probability of Pulmonary Thromboembolism
No. of Risk Factors* Probability of PE (%) 95% CI (%)
None 0.5 0.1, 2
Any one 8 5, 15
Any two 62 46, 76
Any three or more 89 87, 99
Reprinted from Lee et al. Radiology 2012;262:242-251, with 
permission of Radiological Society of North America (18). *Risk 
factors include immobilization, hypercoagulable state, excess 
estrogen state, indwelling central venous catheter, and prior 
pulmonary embolism and/or deep venous thrombosis. CI = 
confidence interval, PE = pulmonary embolism
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Fig. 1. Receiver operative characteristic curve for 
differentiating patients with pulmonary thromboembolism 
from those without pulmonary thromboembolism based on 
total number of risk factors (immobilization, indwelling 
central venous line, prior pulmonary thromboembolism and/
or deep venous thrombosis, hypercoagulable state, and excess 
estrogen state). Dashed line = 45° line of nondiscrimination 
(equivalent to coin tossing). Area under curve of 0.934 indicates 
excellent discrimination (p = 0.0001). Reproduced from Lee et al. 
Radiology 2012;262:242-251, with permission of Radiology Society 
of North America (18). CI = confidence interval
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can be adjusted based on the patient’s size by closely 
following the as low as reasonably achievable principle. 
Based on patient size, specific techniques can be used, 
including manual tube current technique charts, automatic 
exposure control, size-dependent beam-shaping filters, and 
optimal tube potential (21). Lower kilovoltage scanning has 
been shown to increase the percentage of peripheral and 
central pulmonary arteries which can be evaluated while 
decreasing radiation dosage without substantially affecting 
image quality (22). In addition, employing currently 
available dose modulation techniques can further decrease 
the overall radiation dose when performing CTPA in children 
(2, 23-26).
Timing of Bolus
Two primary methods are used for bolus timing, i.e., bolus 
tracking and empiric scan delay. Test bolus administration 
is less often performed in pediatric population. Bolus 
tracking involves placing a region of interest over the 
pulmonary outflow tract or main pulmonary artery by either 
preselecting a desired threshold for the scan to start or 
visually monitoring and manually triggering the scan. After 
contrast material injection, a series of low-dose dynamic 
images are acquired for the region of interest. Once the 
desired Hounsfield units (HU), generally between 150 
and 200 HU, are reached within the region of interest, 
a full diagnostic scan is then triggered. This method is 
advantageous as it allows for the tailoring of scan times 
in real-time for the particular cardiovascular physiology 
of patients. However, this advantage is counterbalanced 
with the possibility that the enhancement threshold will 
never be reached, thus creating an uncertainty for the 
technologist on when to start the scan (20). Additionally, 
some authors have argued that bolus tracking can result in 
less optimal pulmonary arterial enhancement compared to 
the empiric scan delay technique (20), although this has 
not been definitively demonstrated.
The empiric scan delay technique uses a preset time delay 
from the end of the contrast bolus to the beginning of the 
scan, generally ranging from 15 seconds to 25 seconds. This 
simple technique adds uniformity across scans, reducing 
the complexity involved and the potential operator error. 
Therefore, it has been suggested as the technique of choice 
for adult CTPA (20). However, these advantages are less 
certain in children given the wide variances in pediatric 
sizes and heart rates. It is our opinion that generally the 
empiric delay technique is more likely to lead to suboptimal 
vascular enhancement in comparison to bolus tracking in 
the pediatric population. Thus, we advocate bolus timing 
based on the bolus tracking method with preset attenuation 
thresholds or by manual triggering the scan.
Pulmonary arterial enhancement has also been shown 
to be affected by respiratory cycle, i.e., full inspiration, 
expiration, normal breathing, and free-breathing (27-30). It 
has been hypothesized that during full inspiration, contrast 
agent is diluted by differential flow rates in the inferior 
vena cava versus the superior vena cava. Additionally, 
patients may undergo a Valsalva maneuver in full inspiration 
that has been shown to be able to decrease pulmonary 
blood flow (27). Given these hemodynamic effects, shallow 
A B
Fig. 2. 16-year-old boy with history of double outlet right ventricle status post Fontan procedure who presented with shortness 
of breath. 
A. Initial axial enhanced computed tomographic image showing low attenuation area (arrow) within Fontan pathway concerning for possible 
thrombosis. B. Subsequently obtained delayed axial computed tomographic image demonstrating homogeneous opacification of Fontan pathway 
(arrow) similar to other cardiovascular structures, confirming absence of thrombosis.
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free-breathing and expiratory phase scanning have been 
advocated to overcome insufficient pulmonary arterial 
enhancement (27, 30).
One clinical circumstance that is worthy of specific 
consideration is the assessment of pulmonary 
thromboembolism in children who have undergone Fontan 
procedure for congenital heart disease. In these patients, 
contrast enhancement of the pulmonary arteries is often 
suboptimal due to the slow-moving blood flow through the 
Fontan pathway and the lack of contrast material mixing 
A
C
B
D
Fig. 3. Acute pulmonary embolism on dual-energy computed tomography. 
A. Sagittal reformatted image demonstrating occlusive pulmonary embolism (arrow) in posterior basal branch of right pulmonary artery. B. Dual-
energy computed tomography blood pool map demonstrating corresponding wedge-shaped area of decreased perfusion (arrows) in posterior basal 
right lower lobe. C. Coronal reformatted image from contrast-enhanced dual-energy computed tomography demonstrating occlusive thrombus 
(arrows) in left lower lobe pulmonary artery. D. Corresponding tissue-specific thrombus analysis demonstrating thrombus as red filling defect 
(arrows) with blue-shaped pulmonary artery. Images provided by courtesy of Dr. Long Jiang Zhang, Department of Medical Imaging, Jinling 
Hospital, Clinical School of Medical College, Nanjing University, China.
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within the right atrium (Fig. 2). Due to the suboptimal 
contrast within the pulmonary arteries, evaluation for 
pulmonary thromboembolism can be incomplete, which 
can lead to misdiagnosis of pulmonary thromboembolism 
when no thromboembolism is present (31). In a recent 
case series, Prabhu et al. (31) described their experience in 
evaluating 5 pediatric patients who had Fontan procedure 
and multidetector CT (MDCT) for suspected pulmonary 
thromboembolism. Three of the patients were initially 
misdiagnosed as having pulmonary thromboembolism 
due to suboptimal contrast-enhancement technique 
using a single injection of contrast material through an 
upper extremity vein. They described the following three 
technical parameters that could be used to optimize CTPA 
in those patients with a Fontan: simultaneous injection 
of contrast material through lower- and upper-extremity 
veins, the usage of a delayed second-phase scan if there is 
a suboptimal contrast enhancement on the initial images 
or in patients with bilateral Glenn shunts with sluggish 
blood flow in the Fontan circulation or in the pulmonary 
arteries (Fig. 2), and employing bolus tracking with optimal 
contrast enhancement within the Fontan pathway and the 
pulmonary arteries (31). Alternatively, an additional useful 
technique for assessing Fontan pathway thromboembolism 
is to give patient a single intravenous injection of the leg 
at a slow injection rate with a single delay-phase scan at 1–3 
minutes (32).
Dual-Energy CT
Dual-energy CT (DECT) represents a recent technical 
innovation in CT imaging. It allows for both anatomic 
and functional lung imaging in a single test (33). Images 
are acquired by scanning the chest with two different 
X-ray spectra to allow the differentiation of materials of 
different densities based on Compton scatter and electric 
absorption (34). In the chest, a combination of 80 kVp 
and 140 kVp energy spectra are generally employed with 
radiation dose similar to that of single-energy CT (34, 35). 
Images are most often acquired during full inspiration, 
although imaging with free-breathing has been described 
(33). Once the initial dataset is acquired, images are 
post-processed using three-material decomposition by 
differentiating body tissues from lung contrast agents, 
e.g., iodinated intravenous contrast in CT perfusion and 
xenon in CT ventilation imaging (34). In CT perfusion 
imaging, pulmonary vessels can be divided into enhanced 
and unenhanced vessels based on local iodine values. Given 
this ability, one major emerging clinical application for 
DECT is to evaluate pediatric pulmonary thromboembolism 
(Fig. 3). In animal models, CT perfusion imaging has been 
shown to increase the sensitivity of detecting peripheral 
pulmonary thromboembolism (36). With the addition of CT 
ventilation imaging, ventilation/perfusion mismatches may 
be seen, thus increasing the confidence in PE diagnosis. 
Although multiple studies have demonstrated the feasibility 
of this technique for adults, its experience in children 
remains limited. However, with more widespread usage of 
dual-energy technique, DECT, particular perfusion imaging, 
could become the standard technique for pulmonary 
thromboembolism imaging.
Imaging Evaluation
Axial CT Evaluation
Axial CT images are generally the first ones reviewed 
from any chest CT images to determine pulmonary 
thromboembolism. They should be evaluated with soft 
tissue (window [W] = 350, level [L] = 50), lung (W = 1500, 
L = -500), and vascular windows (W = 700, L = 200). 
Evaluation can begin by starting at the level of the main 
pulmonary arteries and working distally within each branch 
of the pulmonary arteries until the artery can no longer 
be identified. Alternatively, one can start from either the 
top or the bottom of the scanning area and evaluate each 
arterial branch by working proximally towards the main 
pulmonary artery. Diagnosis is made by the demonstration 
of direct or indirect findings of acute or chronic pulmonary 
embolus (discussed below) on two or more consecutive 
axial sequences. When pulmonary thromboembolism is 
identified, the pulmonary artery level involved (e.g., 
central, lobar, segmental or subsegmental), the affect 
lobe, and any associated parenchymal changes should be 
documented. After studying 84 children who underwent 98 
CTPAs for pulmonary thromboembolism, Kritsaneepaiboon et 
al. (2) have found that pulmonary emboli located in lobar 
pulmonary arteries occurred in 39% of cases, segmental 
pulmonary arteries in 35% of patients, subsegmental 
pulmonary arteries in 16% of cases, and main or central 
pulmonary arteries in 10% of patients. Right lower lobe 
was found in 37% of cases, which was the most common 
one. Left lower lobe was the next most common (24%), 
followed by right upper lobe in 15% of cases, and the right 
middle lobe or the left upper lobe (12% of cases each) (2). 
Pulmonary thromboembolism was most often bilateral (61%) 
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or multilobar (46%). When pulmonary thromboembolism is 
unilateral, the right lung is often affected (2).
Multiplanar Reformatted CT Image Evaluation
Following acquisition of the initial CT data set, 
multiplanar reformations (MPR) are often generated with 
most institutions routinely generating coronal images (Fig. 
4). Depending on institutional preferences, sagittal and 
oblique planes may also be created. These added planes 
can significantly increase confidence and interobservor 
agreement for pulmonary thromboembolism diagnosis 
as demonstrated in a study by Lee et al. (25) after 
retrospectively reviewing 60 children who underwent CTPA 
for clinically suspected pulmonary thromboembolism. 
They found a diagnostic accuracy of CTPA for pulmonary 
thromboembolism ranging from 91.7% to 100% with a mean 
of 96.7%. In addition, there was no significant difference 
between axial images and MPR MDCT images. However, they 
found that the use of MPR images significantly increased 
the interpretation times and interobservor agreement. 
Thus, additional MPR images may be usefulness for cases 
whose diagnosis of pulmonary thromboembolism is in 
question (25). Extrapolating from their data, one could 
evaluate axial images first. If the diagnosis of pulmonary 
thromboembolism is firmly confirmed or excluded, no 
additional reformation is need. However, if after reviewing 
the axial images, the diagnosis is in question, additional 
MPR images can then be generated. This approach might 
balance accuracy, time efficiency, and reader confidence.
Spectrum of Imaging Findings
The criteria for pulmonary thromboembolism diagnosis 
can be divided based on chronicity (i.e., acute versus 
chronic) and further subdivided based on direct or indirect 
signs of pulmonary thromboembolism.
Acute Pulmonary Thromboembolism Signs
Direct Signs
Direct signs of acute pulmonary thromboembolism have 
been well documented throughout the medical literature. 
They are the same regardless of patient age. The most 
definitive sign is complete arterial occlusion (Fig. 5). 
In this case, there is a failure to completely opacify the 
arterial lumen with the embolus measured at less HU 
than the adjacent opacified blood (20, 37). The affected 
pulmonary artery may be enlarged compared to pulmonary 
A B
Fig. 4. 15-year-old girl with oral contraceptive medication who presented with acute shortness of breath and chest pain. 
A. Axial enhanced computed tomographic image showing low attenuation area (arrow) near right lower lobe pulmonary arteries. It was initially 
interpreted as lymph nodes based on axial computed tomographic image alone. Also noted are bilateral pleural effusions. B. Coronal enhanced 
computed tomographic image demonstrating intraluminal filling defect (arrow) in right lower lobe pulmonary artery, confirming diagnosis of 
pulmonary embolism which was initially overlooked based on axial computed tomographic image alone (A).
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arteries with the same branching order (20). Alternatively, 
if the embolus is not completely occlusive, it may appear as 
a central filling defect surrounded by intravenous contrast 
material (Fig. 4B). A third direct sign of acute pulmonary 
thromboembolism is that a peripheral intraluminal defect 
can form an acute angle with the vessel wall. Any of these 
three direct signs can be present on two or more contiguous 
slices (2, 20).
Indirect Signs
Indirect signs of acute pulmonary thromboembolism are 
divided into indirect vascular signs and lung parenchymal 
changes. Indirect vascular signs include nonuniform 
arterial perfusion and oligemia corresponding to the 
classic Westermark sign on chest radiography. These 
findings are more often seen in cases of severe pulmonary 
thromboembolism. It is difficult to recognize them on chest 
CT. Nevertheless, these findings are more readily apparent 
on CT compared to chest radiography. Occasionally, 
nonuniform arterial perfusion manifests as mosaic pattern 
of lung attenuation on lung windows (Fig. 6). However, 
this findings is more commonly seen in chronic pulmonary 
thromboembolism (20).
By contrast, lung parenchymal changes are readily 
demonstrable, including wedge-shaped peripheral 
consolidation, linear opacities, pleural effusions, ground-
glass opacities, atelectasis, nodules, and focal patchy 
increased attenuation (Fig. 7). On review of the above list 
of parenchymal changes, it is apparent that most of these 
findings are nonspecific with a rather long differential 
diagnosis. However, after evaluating lung parenchymal and 
pleural abnormalities in children with or without pulmonary 
thromboembolism, Lee et al. (26) found that wedge-shaped 
areas of consolidation were significantly more common in 
children with pulmonary thromboembolism than in those 
without pulmonary thromboembolism (36% of children with 
pulmonary thromboembolism and 9% of children without 
pulmonary thromboembolism, p = 0.03). Nevertheless, 
indirect signs of acute pulmonary thromboembolism 
other than wedge-shaped consolidations have limited 
usefulness. They might help direct the interpreting 
radiologist to carefully look for direct signs of pulmonary 
thromboembolism in the involved area.
Chronic Pulmonary Thromboembolism Signs
Direct Signs
Direct signs of chronic pulmonary thromboembolism 
have a more varied morphology in comparison to acute 
pulmonary thromboembolism direct signs. Chronic 
pulmonary thromboembolism may appear as intraluminal 
filling defect present for more than 3 months with acute 
pulmonary thromboembolism morphology. Alternatively, 
the vessels may be completely occluded and permanently 
shrunken compared to its neighboring vessels. An eccentric 
filling defect forming an obtuse margin with the vessel wall 
Fig. 5. 4-year-old girl with neuroblastoma who presented with 
shortness of breath and chest pain. Axial enhanced computed 
tomographic image showing bilateral pulmonary embolism (arrows).
Fig. 6. 17-year-old African-American male with recent history 
of immobilization after motor vehicle collision and acute 
onset of tachycardia. Axial contrast-enhanced chest computed 
tomographic image through lower lobe demonstrating small bilateral 
pleural effusions and peripheral opacities, some of which are wedge-
shaped (arrows), consistent with parenchymal changes of pulmonary 
emboli (not shown on this). Additionally, there is subtle mosaic 
attenuation of lungs with lower lobes more opacified in respect to 
partially visualized right middle lobe and lingula, subtle indirect 
finding of pulmonary emboli due to nonuniform perfusion.
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(Fig. 8) may be seen (20). Additional direct signs include 
intraluminal web or band within an otherwise contrast-
opacified artery and apparent thick-walled artery with 
contrast passing through irregular lumen representing 
recanalization within chronic thrombus (20). Occasionally, 
chronic pulmonary emboli may be calcified.
Indirect Signs
Much like indirect signs of acute pulmonary 
thromboembolism that mostly serve as a harbinger of 
pulmonary thromboembolism and direct the radiologist to 
areas for closer scrutiny, indirect signs of chronic pulmonary 
thromboembolism are also largely nonspecific. As mentioned 
above, mosaic attenuation of lungs is more commonly seen 
in chronic rather than acute pulmonary thromboembolism 
as a manifestation of non-uniform arterial perfusion (20). 
Other indirect signs of chronic pulmonary thromboembolism 
include enlargement of the bronchial arteries, tortuous 
pulmonary vessels, poststenotic arterial dilatation, and 
abrupt cutoff of a pulmonary artery or peripheral pruning 
(20, 38). Signs of pulmonary hypertension with right heart 
enlargement and pulmonary arterial enlargement may be 
present.
CT Perfusion Findings
In addition to the direct and indirect signs of pulmonary 
thromboembolism demonstrated on standard axial CT 
images, lung perfusion defects or abnormalities can 
be seen on axial overlaid DECT images (Fig. 3). Here, 
perfusion abnormalities are dependent on the overall 
thrombotic burden and the site as well as the extent of 
vessel occlusion. In general, occlusive thrombi demonstrate 
focal or regional perfusion defects that have been shown 
to correlate well with the lack of lung perfusion on other 
imaging modalities (33, 34, 39-42).
Fig. 7. 15-year-old girl with repaired congenital heart disease who presented with acute right sided chest pain. 
A. Axial enhanced computed tomographic image showing filling defect (arrow) in right lower lobe segmental pulmonary artery. Also noted is 
right pleural effusion. B. Axial lung window computed tomographic showing wedge shaped (arrows) opacity consistent with lung infarction from 
pulmonary embolism.
A B
Fig. 8. 16-year-old girl with oral contraceptive medication 
and chronic pulmonary embolism. Coronal maximum intensity 
projection computed tomographic image showing eccentric filling 
defects (arrows) which form obtuse margin with vessel wall. Also 
noted are several prominent enlarged bronchial arteries (arrowheads) 
coursing along pulmonary arteries containing chronic pulmonary 
embolism.
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Alternative Diagnoses
Similar to adults where significant alternative diagnosis 
has been made for majority of patients who are clinically 
suspected of pulmonary thromboembolism, over half of 
children suspected of having pulmonary thromboembolism 
do not have pulmonary emboli or an alternative diagnosis 
discovered at CT (24). Thus, it is imperative for the 
interpreting radiologist to be aware of these alternative 
diagnoses before interpreting CTPA for pediatric pulmonary 
thromboembolism. In a recent study, of 89 children with 
age ranging from 2 months to 18 years who underwent 96 
CTPAs but found not to have pulmonary thromboembolism, 
59% of patients are found to have alternative diagnosis (24). 
The most common alternative diagnoses are pneumonia and 
atelectasis. One of these two diagnoses were found in 77% 
(44/57) of patients, including atelectasis in 22 patients 
and pneumonia in 22 patients. The next most common 
alternative diagnosis is malignancy (5%). Congenital heart 
disease, pulmonary hypertension, and pericardial effusion 
are each found in 3.5% of cases. Lastly, pulmonary nodules, 
rib fractures, right atrial thrombus, and fat embolism are 
each found in 1.8% of cases (24). These findings buoy 
the fact that a systematic search beyond pulmonary 
arteries is warranted in all MDCT for pediatric pulmonary 
thromboembolism.
CONCLUSION
Once thought to be rare, recent research studies have 
demonstrated that pediatric pulmonary thromboembolism 
has a higher prevalence than previously thought. 
Historically, lung ventilation-perfusion scintigraphy (VQ 
scan) has served as the first-line modality to detect 
pediatric pulmonary thromboembolism. However, CT is 
currently the imaging modality of choice with VQ scans 
primarily serving secondarily as a problem solving tool. 
Although imaging interpretation for pediatric pulmonary 
thromboembolism is similar to that for adults, awareness 
of alternative diagnosis as well as up-to-date low dose CT 
techniques, particularly DECT lung perfusion imaging, is 
imperative for optimal scan quality and interpretation (43). 
Furthermore, recently described and future risk stratification 
algorithms will likely begin to be routinely incorporated 
into clinical practice. This could potentially decrease 
pediatric radiation exposure by only performing CT in those 
at high risk of pulmonary thromboembolism.
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